Invite a friend!

Seattle Genetics Inc

Address
21823 30th Dr SE Bothell WA 98021
Phone
(425) 527-4000
Visit:
seattlegenetics.com
Is this your business?
Claim it now!
Something wrong?
Submit a correction
Recommend It? Recommended0 Not Recommended0
Average Rating
0
Total Reviews
(2)
Leave a review with:
  1. 1 Star
  2. 2 Stars
  3. 3 Stars
  4. 4 Stars
  5. 5 Stars
Is this your business? Claim it now!
Share on
Share

Contact Us

Email the business

Fax
(425) 489-4798

Business Hours

Status: Closed

Sunday
Closed
Monday
8:00am-5:00pm
Tuesday
8:00am-5:00pm
Wednesday
8:00am-5:00pm
Thursday
8:00am-5:00pm
Friday
8:00am-5:00pm
Saturday
Closed

Tags

Analytical Laboratories Attorneys & lawyers Attorneys referral service BIOLOGICAL PRODUCTS BIOLOGICAL PRODUCTS: Except Diagnostic Biological Research Biopharmaceuticals & Biotherapeutics Manufacturing BioTech Biotechnology Product Manufacturing Biotechnology Products & Services Bothell, WA, United States Builders & Contractors Business Services Business to Business Businesses and Services commercial physical research commercial research laboratory Construction engineering Government Contractors Laboratories Laboratories Research & Development LABORATORIES: Commercial Nonphysical Research laboratory life sciences Manufacturing noncommercial research organizations Number of employees: 100 to 249 Office Other Contractors Physicians-md & do Professional Services R&D Laboratories Research research & development in the physical Research & development laboratories Research and Development Laboratories Research Services Scientific Equipment & Supplies Scientific Equipment & Supply Special Trade Contractors Referral Service Surgeons

Submit a correction

Know more about this business than we do? Cool! Please submit any corrections or missing details you may have.

Help us make it right

What the community has to say about Seattle Genetics Inc

Information about this business (1)

; Seattle genetics is a biotechnology Company focused on developing monoclonal ANTIBODY-BASED therapeutics for cancer and immunologic diseases. The targeting ability of MABS provides a means to identify and kill cancer cells while limiting damage to normal tissue. Additionally. The Company has more than 130 employees and is located in a HIGH-TECHNOLOGY campus in Bothell. Wash. Seattle genetics...

Posted on June 27, 2011. Brought to you by yellowpages.

Reviews of this business (1)

Share a review

Overall review sentiment

Score
%

Top 3 sentiment words

Overall review sentiment

Score
%

Rating distribution

5 stars
0
4 stars
0
3 stars
0
2 stars
0
1 star
0
No rating
1
See more reputation details

Other reviews from the web (1)

Check out Building. Awesome Tesla Roadster parked out front.

Posted on January 12, 2013. Brought to you by ziplocal.

Business description (4)

Seattle Genetics can be found at 30th Dr Se 21823. The following is offered: Laboratories. The entry is present with us since Sep 8, 2010 and was last updated on Nov 14, 2013. In Bothell there are 2 other Laboratories. An overview can be found here.

Posted on September 23, 2015. Brought to you by opendius.

Seattle Genetics is located at 21823 30th Dr SE, Bothell, WA. This location is in the Canyon Park neighborhood. This business specializes in Laboratories.

Posted on April 21, 2015. Brought to you by merchantcircle.

To heck with verbs, Seattle Genetics is conjugating antibodies and drugs to fight cancer. The company's technologies use genetically engineered monoclonal antibodies (MAbs, or single source proteins) to trigger cell death in some cancers, but when they can't do it alone, Seattle Genetics pairs them up with drugs using its Antibody-Drug Conjugate (ADC) technology for a one-two punch. Its first...

Posted on September 09, 2014. Brought to you by hoovers.

Seattle Genetics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in pivotal trial for patients with relapsed or refractory hodgkin lymphoma. The company’s other product candidates in various stages of clinical trials include dacetuzumab...

Posted on August 26, 2011. Brought to you by crunchbase.

© 2007-2026 Solfo, Inc. – All rights reserved